HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
2.575
-0.145 (-5.33%)
Nov 21, 2024, 10:30 AM EST - Market open
HOOKIPA Pharma Employees
As of December 31, 2023, HOOKIPA Pharma had 179 total employees, including 151 full-time and 28 part-time employees. The number of employees increased by 1 or 0.56% compared to the previous year.
Employees
179
Change (1Y)
1
Growth (1Y)
0.56%
Revenue / Employee
$279,324
Profits / Employee
-$242,296
Market Cap
30.39M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
FibroGen | 486 |
Co-Diagnostics | 155 |
Barinthus Biotherapeutics | 130 |
Carisma Therapeutics | 107 |
Citius Pharmaceuticals | 22 |
BioVie | 14 |
Iterum Therapeutics | 14 |
Eterna Therapeutics | 8 |
HOOK News
- 9 days ago - HOOKIPA Pharma's Eseba-vec Highlighted in SITC Late-Breaker - GlobeNewsWire
- 21 days ago - HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 - GlobeNewsWire
- 22 days ago - HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer - GlobeNewsWire
- 2 months ago - HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset - GlobeNewsWire
- 2 months ago - Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm - Business Wire
- 2 months ago - HOOKIPA Pharma Announces Board of Directors Changes - GlobeNewsWire
- 3 months ago - HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire